Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia - - BioPharm International

ADVERTISEMENT

Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia



Novartis reported that 2 million treatments of its pediatric antimalarial are arriving in Zambia due to collaboration with Malaria No More's Power of One campaign, a global digital fundraising operation. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One million treatments of coartem dispersible have been funded through public donations and Novartis matched these with a further one million treatments.

The campaign, which launched to the public in September 2013, uses social, mobile, and e-commerce technologies, enabling the public to purchase treatments for children in Zambia. Novartis is supporting the campaign financially and has pledged to match up to one million treatments funded by the public every year through 2015. Since 2009, Novartis has delivered over 600 million treatments, of which more than 200 million were treatments developed specifically for children, without profit to malaria-endemic countries.

Source: Novartis

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines

Click here